ASPIRIN USE MAY BE ASSOCIATED WITH DECREASED CANCER RISK
This article was originally published in The Tan Sheet
ASPIRIN USE MAY BE ASSOCIATED WITH DECREASED CANCER RISK based on an analysis of data from the National Health and Nutrition Examination Survey I (NHANES I) and the NHANES I Epidemiologic Follow-Up Studies (NHEFS). In a study published in the March issue of Epidemiology, Dina Schreinemachers and Richard Everson, Health Effects Research Laboratory of the Environmental Protection Agency, noted that the data in NHANES I and NHEFS "suggest an association between aspirin consumption and decreased cancer incidence at several cancer sites."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC